These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 23297181)

  • 41. RNA-virus proteases counteracting host innate immunity.
    Lei J; Hilgenfeld R
    FEBS Lett; 2017 Oct; 591(20):3190-3210. PubMed ID: 28850669
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Oral inflammation, a role for antimicrobial peptide modulation of cytokine and chemokine responses.
    Brogden KA; Johnson GK; Vincent SD; Abbasi T; Vali S
    Expert Rev Anti Infect Ther; 2013 Oct; 11(10):1097-113. PubMed ID: 24124799
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Innate immune function by Toll-like receptors: distinct responses in newborns and the elderly.
    Kollmann TR; Levy O; Montgomery RR; Goriely S
    Immunity; 2012 Nov; 37(5):771-83. PubMed ID: 23159225
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Modulating immunity as a therapy for bacterial infections.
    Hancock RE; Nijnik A; Philpott DJ
    Nat Rev Microbiol; 2012 Mar; 10(4):243-54. PubMed ID: 22421877
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Toll-like receptors and the host defense against microbial pathogens: bringing specificity to the innate-immune system.
    Netea MG; van der Graaf C; Van der Meer JW; Kullberg BJ
    J Leukoc Biol; 2004 May; 75(5):749-55. PubMed ID: 15075354
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interactions Between the Gut Microbiota and the Host Innate Immune Response Against Pathogens.
    Cheng HY; Ning MX; Chen DK; Ma WT
    Front Immunol; 2019; 10():607. PubMed ID: 30984184
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immaturity of infection control in preterm and term newborns is associated with impaired toll-like receptor signaling.
    Sadeghi K; Berger A; Langgartner M; Prusa AR; Hayde M; Herkner K; Pollak A; Spittler A; Forster-Waldl E
    J Infect Dis; 2007 Jan; 195(2):296-302. PubMed ID: 17191175
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The innate immune system and its relevance to neonatal sepsis.
    Kenzel S; Henneke P
    Curr Opin Infect Dis; 2006 Jun; 19(3):264-70. PubMed ID: 16645488
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mechanisms and pathways of innate immune activation and regulation in health and cancer.
    Cui J; Chen Y; Wang HY; Wang RF
    Hum Vaccin Immunother; 2014; 10(11):3270-85. PubMed ID: 25625930
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inflammasomes, Autophagy, and Cell Death: The Trinity of Innate Host Defense against Intracellular Bacteria.
    Krakauer T
    Mediators Inflamm; 2019; 2019():2471215. PubMed ID: 30728749
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Detection of Viral Infections by Innate Immunity.
    Carty M; Guy C; Bowie AG
    Biochem Pharmacol; 2021 Jan; 183():114316. PubMed ID: 33152343
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Toll-like receptors: recognition receptors of the innate immune system and target structures for therapeutical intervention].
    Kabelitz D
    Med Monatsschr Pharm; 2012 Jul; 35(7):238-44. PubMed ID: 22852274
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The innate immune response during liver inflammation and metabolic disease.
    Bieghs V; Trautwein C
    Trends Immunol; 2013 Sep; 34(9):446-52. PubMed ID: 23668977
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Microbial Phagocytic Receptors and Their Potential Involvement in Cytokine Induction in Macrophages.
    Fu YL; Harrison RE
    Front Immunol; 2021; 12():662063. PubMed ID: 33995386
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A neonatal model of intravenous Staphylococcus epidermidis infection in mice <24 h old enables characterization of early innate immune responses.
    Kronforst KD; Mancuso CJ; Pettengill M; Ninkovic J; Power Coombs MR; Stevens C; Otto M; Mallard C; Wang X; Goldmann D; Levy O
    PLoS One; 2012; 7(9):e43897. PubMed ID: 22970147
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Toll-like receptor 8 agonist nanoparticles mimic immunomodulating effects of the live BCG vaccine and enhance neonatal innate and adaptive immune responses.
    Dowling DJ; Scott EA; Scheid A; Bergelson I; Joshi S; Pietrasanta C; Brightman S; Sanchez-Schmitz G; Van Haren SD; Ninković J; Kats D; Guiducci C; de Titta A; Bonner DK; Hirosue S; Swartz MA; Hubbell JA; Levy O
    J Allergy Clin Immunol; 2017 Nov; 140(5):1339-1350. PubMed ID: 28343701
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Recognition of bacterial infection by innate immune sensors.
    Kumar S; Ingle H; Prasad DV; Kumar H
    Crit Rev Microbiol; 2013 Aug; 39(3):229-46. PubMed ID: 22866947
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Toll-Like receptors (TLRs) and their ligands.
    Uematsu S; Akira S
    Handb Exp Pharmacol; 2008; (183):1-20. PubMed ID: 18071652
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Innate immune recognition of viral infection.
    Kawai T; Akira S
    Nat Immunol; 2006 Feb; 7(2):131-7. PubMed ID: 16424890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.